Drug Shortage Report for AURO-OLANZAPINE ODT
Report ID | 128776 |
Drug Identification Number | 02448726 |
Brand name | AURO-OLANZAPINE ODT |
Common or Proper name | Olanzapine |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 3 X 10 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-11-20 |
Estimated end date | 2022-02-10 |
Actual end date | 2022-01-07 |
Shortage status | Resolved |
Updated date | 2022-02-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2022-02-09 | French | Compare |
v15 | 2022-02-09 | English | Compare |
v14 | 2021-12-30 | French | Compare |
v13 | 2021-12-30 | English | Compare |
v12 | 2021-10-29 | French | Compare |
v11 | 2021-10-29 | English | Compare |
v10 | 2021-10-01 | French | Compare |
v9 | 2021-10-01 | English | Compare |
v8 | 2021-08-03 | French | Compare |
v7 | 2021-08-03 | English | Compare |
v6 | 2021-03-31 | French | Compare |
v5 | 2021-03-31 | English | Compare |
v4 | 2021-01-29 | French | Compare |
v3 | 2021-01-29 | English | Compare |
v2 | 2020-11-24 | French | Compare |
v1 | 2020-11-24 | English | Compare |
Showing 1 to 16 of 16